Mechanistic insights into the differential efficacy of Daptomycin Plus β-Lactam combinations against Daptomycin-Resistant Enterococcus faecium
Cargando...
Fecha
2020
Título de la revista
Publicado en
Journal of infectious diseases, 1537-6613, Vol. 222, Nro. 9, 2020, 1531-1539
Publicado por
Oxford University Press
URL de la fuente
ISSN de la revista
Título del volumen
Resumen
Descripción
Abstract
Background
The combination of daptomycin (DAP) plus ampicillin (AMP), ertapenem (ERT), or ceftaroline has been demonstrated to be efficacious against a DAP-tolerant Enterococcus faecium strain (HOU503). However, the mechanism for the efficacy of these combinations against DAP-resistant (DAP-R) E. faecium strains is unknown.
Methods
We investigated the efficacy of DAP in combination with AMP, ERT, ceftaroline, ceftriaxone, or amoxicillin against DAP-R E. faecium R497 using established in vitro and in vivo models. We evaluated pbp expression, levels of penicillin-binding protein (PBP) 5 (PBP5) and β-lactam binding affinity in HOU503 versus R497.
Results
DAP plus AMP was the only efficacious regimen against DAP-R R497 and prevented emergence of resistance. DAP at 8, 6, and 4 mg/kg in combination with AMP was efficacious but showed delayed killing compared with 10 mg/kg. PBP5 of HOU503 exhibited amino acid substitutions in the penicillin-binding domain relative to R497. No difference in pbp mRNA or PBP5 levels was detected between HOU503 and R497. labeling of PBPs with Bocillin FL, a fluorescent penicillin derivative, showed increased β-lactam binding affinity of PBP5 of HOU503 compared with that of R497.
Conclusions
Only DAP (10 mg/kg) plus AMP or amoxicillin was efficacious against a DAP-R E. faecium strain, and pbp5 alleles may be important contributors to efficacy of DAP plus β-lactam therapy.
Palabras clave
Keywords
Vancomycin-resistant E. faecium, E. faecium, Daptomycin, β-lactam, PBP